Pliant Therapeutics, Inc.
PLRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$210 | -$161 | -$123 | -$97 |
| Dep. & Amort. | $2 | $2 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $38 | $44 | $23 | $10 |
| Change in WC | $9 | $1 | $4 | $7 |
| Other Non-Cash | $6 | -$3 | $0 | $3 |
| Operating Cash Flow | -$156 | -$116 | -$95 | -$75 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$1 | -$2 | -$2 |
| Net Acquisitions | $0 | $0 | $148 | -$76 |
| Inv. Purchases | -$211 | -$583 | -$326 | -$220 |
| Inv. Sales/Matur. | $355 | $457 | $177 | $296 |
| Other Inv. Act. | $0 | $0 | -$148 | $76 |
| Investing Cash Flow | $140 | -$127 | -$150 | $74 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $20 | $0 | $10 | $0 |
| Stock Issued | $3 | $275 | $216 | $3 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$1 | $1 | -$0 |
| Financing Cash Flow | $23 | $274 | $227 | $3 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $8 | $31 | -$18 | $1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $65 | $34 | $52 | $51 |
| End Cash | $73 | $65 | $34 | $52 |
| Free Cash Flow | -$159 | -$117 | -$96 | -$77 |